Request Trial
shutterstock_1744932446_cameracraft
CameraCraft / Shutterstock.com
30 May 2023Marisa Woutersen

UPC releases contingency plan for hard copy opt-outs

Court outlines submission method in the event of CMS failure | Hard-copy format requirements include USB stick and delivery to Luxembourg | Guidelines have “made people nervous” say lawyers | Full details on how to submit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
USPTO director steps into Sun Pharma’s PTAB-ITC clash
31 July 2026   A director review has overturned a PTAB ruling, questioning why it diverged from an ITC decision based on the same patent claims, prior art and evidence.
Careers
USPTO appoints new acting commissioner for patents
31 July 2026   The ex-Greenberg Traurig shareholder will oversee the office’s 14,000-strong patent division, as the agency prepares for the departure of deputy director Coke Morgan Stewart.
MedTech
European court strikes down hearing aid sensor patent
30 July 2026   A dispute over optical sensor technology in miniature hearing devices ended with the EPO revoking a patent, finding the invention obvious despite ruling it was new over the closest prior art.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

More features

USPTO director steps into Sun Pharma’s PTAB-ITC clash
USPTO appoints new acting commissioner for patents
European court strikes down hearing aid sensor patent
Where Big Pharma is betting big in the M&A boom
Fish & Richardson adds AI and medical device specialist
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?
FisherBroyles and Hong Kong affiliate draft in senior partners